LEP and anemia (phenotype): Further research indicates that SGLT2i may improve insulin resistance by lowering leptin and glucose levels, ameliorate anemia, reduce activation of carotid bodies, and inhibit neuronal activation in the third ventricle of the hypothalamus by lowering blood sodium levels, thus exerting a sympatholytic effect (10).